SWISSX
Soursop Reserve.
A premium vapor concept pairing a carefully formulated soursop botanical profile with an engineered glass-and-ceramic pathway designed around material purity, consistency and refined sensory experience.
No inhaled product is risk-free. Product performance, chemistry, emissions and toxicology require independent laboratory validation before commercial claims or sale.
Why glass and ceramic?
The strongest defensible benefit is not that glass or ceramic makes vaping safe. It is that properly specified inert materials can reduce unnecessary contact with reactive or flavor-altering components and support a cleaner, more controlled product architecture.
Flavor neutrality
Borosilicate glass is widely selected where low odor transfer and visual inspection of liquids are desirable.
Thermal control
A purpose-built ceramic heating element can be engineered for even heat distribution, subject to real-device validation.
Premium tactility
Glass and ceramic create a substantial, reusable and visually distinctive format suited to a reserve-class product.
Soursop, treated with restraint.
Soursop (Annona muricata) has a long history of traditional use and is the subject of laboratory research. That does not establish that inhaling a soursop extract provides a health benefit.
The product story should focus on provenance, sensory character, batch identity, material selection and laboratory transparency—not claims to treat, cure or prevent disease.
Reserve Standard
Every commercial batch should publish ingredient identity, contaminant screening, aerosol emissions testing, cannabinoid/nicotine status, solvent residues and a certificate of analysis.
SWISSX describes its cartomizer intellectual-property portfolio as having a present-day value of approximately four billion U.S. dollars.
*Company valuation statement. Not independently verified in this website. Ownership, chain of title, patent status, geographic scope and valuation should be confirmed by qualified patent counsel and an independent valuation expert.
A platform built around the cartomizer.
U.S. Patent 9,351,522 describes a cartomizer architecture integrating a liquid chamber, atomization chamber, guiding wick and power unit. The public patent record confirms the technical subject matter; it does not by itself verify the current SWISSX ownership or the asserted valuation.
View public patent recordThe real Reserve system.
These images are loaded directly from the SWISSX Island media library and show the current battery, cartridge packaging, complete kit and 15 mL and 30 mL Reserve Oil formats.
These image URLs are embedded directly from island.swissx.com. Replace them only if the files move.
Choose your preferred format.
Each SWISSX Soursop Reserve device includes one prefilled 500 mg glass-and-ceramic cartridge. Optional cartridge and bottle formats are available for adult consumers, subject to local law and product testing.
Device Starter Set
Premium reusable device supplied with one prefilled 500 mg glass reservoir and ceramic heating cartridge.
Request availabilityReserve Cartridge
Optional higher-capacity prefilled glass-and-ceramic cartridge for compatible SWISSX devices.
Request availabilityReserve Bottle
30,000 mg total-content format. Listed promotional price: $39.95. For lawful adult use only; not sold as a vaccine, medicine, or disease-prevention product.
Request availability“mg” must be defined on the final label—such as total extract mass, active compound mass, or another verified measure. Do not publish potency claims until confirmed by an accredited laboratory.
Premium does not mean harmless.
No medical claims
SWISSX Soursop Reserve should not be presented as diagnosing, treating, curing or preventing cancer, pain, inflammation or any other disease.
Inhalation testing first
An ingredient considered acceptable in food or topical products is not automatically safe when heated and inhaled.
Adult access only
Not for minors, pregnant people, non-users, or people with respiratory or cardiovascular conditions without medical advice.
Public-health references
The CDC states that e-cigarette aerosol is not harmless water vapor and may contain harmful substances. The FDA warns against vaping products marketed with unproven health claims, including products containing herbal extracts, vitamins or essential oils.
CDC: About e-cigarettes · FDA: Unproven vaping health claims
Request the technical dossier.
For qualified distributors, laboratories, regulators and licensing partners. Replace the sample contact details below before publication.